Clinical trialists recently have shown interest in two-stage procedures for updating the sample-size calculation at an interim point in a trial. Because many clinical trials involve repeated measures designs, it is desirable to have available practical two-stage procedures for such designs. Shih and Gould (1995, Statistics in Medicine 14, 2239-2248) discuss sample-size redetermination for repeated measures studies but under a highly simplified setup. We develop two-stage procedures under the general mixed linear model, allowing for dropouts and missed visits. We present a range of procedures and compare their Type I error and power by simulation. We find that, in general, the achieved power is brought considerably closer to the required level without inflating the Type I error rate. We also derive an inflation factor that ensures the power requirement is more closely met.
No takes yet. Share an insight, caveat, or question.
Zucker et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: